The role of classical and alternative macrophages in the immunopathogenesis of herpes simplex virus-induced inflammation in a mouse model

Journal of Dermatological Science

Volumn 73, Issue 3, 2014, Pages 198-208

  Anower, A K M M ^a   Shim, Ju A ^a   Choi, Bunsoon ^a   Kwon, Hyuk Jae ^a   Sohn, Seonghyang ^a  

^a Ajou University   (South Korea)

Author keywords

Beh et's disease; CD16 32 and CD23; Classical and alternative macrophages; Herpes simplex virus 1; Mouse model

Indexed keywords

BEHÇET'S DISEASE; CD16/32 AND CD23; CLASSICAL AND ALTERNATIVE MACROPHAGES; HERPES SIMPLEX VIRUS 1; MOUSE MODEL;

ANIMALS; BEHCET SYNDROME; COLCHICINE; DISEASE MODELS, ANIMAL; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-4; INTERLEUKIN-6; MACROPHAGES; MALE; MICE; MICE, INBRED ICR; PENTOXIFYLLINE; PHENOTYPE; SIMPLEXVIRUS;

EID: 84895146377     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.11.001     Document Type: Article

References (40)

1. Barker R.N., Erwig L.P., Hill K.S., Devine A., Pearce W.P., Rees A.J. Antigen presentation by macrophages is enhanced by the uptake of necrotic, but not apoptotic, cells. Clin Exp Immunol 2002, 127:220-225.
2. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
3. Stout R.D., Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004, 76:509-513.
4. Gratchev A., Kzhyshkowska J., Kothe K., Muller-Molinet I., Kannookadan S., Utikal J., et al. Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals. Immunobiology 2006, 211:473-486.
5. Sakane T., Takeno M., Suzuki N., Inaba G. Behcet's disease. N Engl J Med 1999, 341:1284-1291.
6. Behcet H. Über rezidivierende, aphthöse, durch ein virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 1937, 105:1152-1157.
7. Lee S., Bang D., Cho Y.H., Lee E.S., Sohn S. Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behcet's disease. Arch Dermatol Res 1996, 288:179-183.
8. Eglin R.P., Lehner T., Subak-Sharpe J.H. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behcet's syndrome and recurrent oral ulcers. Lancet 1982, 2:1356-1361.
9. Sohn S., Lee E.S., Bang D., Lee S. Behcet's disease-like symptoms induced by the Herpes simplex virus in ICR mice. Eur J Dermatol 1998, 8:21-23.
10. Alpsoy E., Kodelja V., Goerdt S., Orfanos C.E., Zouboulis Ch C. Serum of patients with Behcet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology 2003, 206:225-232.
11. Mege J.L., Dilsen N., Sanguedolce V., Gul A., Bongrand P., Roux H., et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993, 20:1544-1549.
12. Bogdan C., Schleicher U. Production of interferon-gamma by myeloid cells - fact or fancy?. Trends Immunol 2006, 27:282-290.
13. Sohn S., Lee E.S., Bang D. Learning from HSV-infected mice as a model of Behcet's disease. Clin Exp Rheumatol 2012, 30:S96-S103.
14. Mosser D.M. The many faces of macrophage activation. J Leukoc Biol 2003, 73:209-212.
15. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
16. Harty J.T., Tvinnereim A.R., White D.W. CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol 2000, 18:275-308.
17. Zhang X., Goncalves R., Mosser D.M. The isolation and characterization of murine macrophages. Curr Protoc Immunol 2008, Chapter 14: Unit 14 11.
18. Sohn S., Lee E.S., Bang D., Li G.Z., Hur Y.K., Lee S. The possible role of T cell and macrophage in development of Behçet's disease-like symptoms induced by herpes simplex virus in ICR mice. Korean J Invest Dermatol 1998, 5:69-76.
19. Sohn S., Lee E.S., Kwon H.J., Lee S.I., Bang D., Lee S. Expression of Th2 cytokines decreases the development of and improves Behcet's disease-like symptoms induced by herpes simplex virus in mice. J Infect Dis 2001, 183:1180-1186.
20. Hamzaoui K., Ayed K., Slim A., Hamza M., Touraine J. Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behcet's disease. Clin Exp Immunol 1990, 79:28-34.
21. Sayinalp N., Ozcebe O.I., Ozdemir O., Haznedaroglu I.C., Dundar S., Kirazli S. Cytokines in Behcet's disease. J Rheumatol 1996, 23:321-322.
22. Alpsoy E., Cayirli C., Er H., Yilmaz E. The levels of plasma interleukin-2 and soluble interleukin-2R in Behcet's disease: a marker of disease activity. J Dermatol 1998, 25:513-516.
23. Davtyan T.K., Mkrtchyan N.R., Manukyan H.M., Avetisyan S.A. Dexamethasone, colchicine and iodine-lithium-alpha-dextrin act differentially on the oxidative burst and endotoxin tolerance induction in vitro in patients with Behcet's disease. Int Immunopharmacol 2006, 6:396-407.
24. Umezawa K. Possible role of peritoneal NF-kappaB in peripheral inflammation and cancer: lessons from the inhibitor DHMEQ. Biomed Pharmacother 2011, 65:252-259.
25. Sager H., Bertoni G., Jungi T.W. Differences between B cell and macrophage transformation by the bovine parasite, Theileria annulata: a clonal approach. J Immunol 1998, 161:335-341.
26. Tripathi S., Bruch D., Kittur D.S. Ginger extract inhibits LPS induced macrophage activation and function. BMC Complement Altern Med 2008, 8:1.
27. Varin A., Mukhopadhyay S., Herbein G., Gordon S. Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 2010, 115:353-362.
28. Li K., Xu W., Guo Q., Jiang Z., Wang P., Yue Y., et al. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ Res 2009, 105:353-364.
29. Lee K.H., Kim H.S., Kaneko F., Bang D. Cytokine production peripheral blood mononuclear cells stimulated with Streptococcus sanguis antigen in patients with Behçet's disease. Korean J Invest Dermatol 2002, 9:183-190.
30. Montaner L.J., da Silva R.P., Sun J., Sutterwala S., Hollinshead M., Vaux D., et al. Type 1 and type 2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-gamma or IL-10. J Immunol 1999, 162:4606-4613.
31. Rowell J.F., Griffin D.E. The inflammatory response to nonfatal Sindbis virus infection of the nervous system is more severe in SJL than in BALB/c mice and is associated with low levels of IL-4 mRNA and high levels of IL-10-producing CD4+ T cells. J Immunol 1999, 162:1624-1632.
32. Yamakawa Y., Sugita Y., Nagatani T., Takahashi S., Yamakawa T., Tanaka S., et al. Interleukin-6 (IL-6) in patients with Behcet's disease. J Dermatol Sci 1996, 11:189-195.
33. Chi W., Zhu X., Yang P., Liu X., Lin X., Zhou H., et al. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci 2008, 49:3058-3064.
34. Shimizu J., Takai K., Fujiwara N., Arimitsu N., Ueda Y., Wakisaka S., et al. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-gamma in patients with Behcet's disease. Clin Exp Immunol 2012, 168:68-74.
35. Shim J., Byun H.O., Lee Y.D., Lee E.S., Sohn S. Interleukin-6 small interfering RNA improved the herpes simplex virus-induced systemic inflammation in vivo Behcet's disease-like mouse model. Gene Ther 2009, 16:415-425.
36. Harper R.M., Allen B.S. Use of colchicine in the treatment of Behcet's disease. Int J Dermatol 1982, 21:551-554.
37. Yasui K., Ohta K., Kobayashi M., Aizawa T., Komiyama A. Successful treatment of Behcet disease with pentoxifylline. Ann Intern Med 1996, 124:891-893.
38. Marques-da-Silva C., Chaves M.M., Castro N.G., Coutinho-Silva R., Guimaraes M.Z. Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action. Br J Pharmacol 2011, 163:912-926.
39. Vukanic Z.S., Colic M., Dimitrijevic M. Effect of pentoxifylline on differentiation and maturation of human monocyte-derived dendritic cells in vitro. Int Immunopharmacol 2007, 7:167-174.
40. Ji Q., Zhang L., Jia H., Xu J. Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines. Ann Clin Lab Sci 2004, 34:427-436.